Legal Opinion
Boehringer Ingelheim International GmbH v. Barr Laboratories, Inc.
Court of Appeals for the Federal Circuit
Decided January 25, 2010No. 2009-1032PublishedCited by 29 opinions
1Opinion of the Court
Opinion for the court filed by Circuit Judge LINN. Opinion dissenting-in-part filed by Circuit Judge DYK.
LINN, Circuit Judge.
This is a patent infringement case involving the effectiveness of a terminal disclaimer to overcome obviousness-type double patenting and the safe-harbor provision of 35 U.S.C. § 121. Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. (collectively “Boehringer”) appeal from a final judgment that Boehringer’s U.S. Patent No. 4,886,812 (the “'812 patent”) is invalid for obviousness-type double patenting. Boehringer Ingelheim Int’l GmbH…
2Cases cited16 opinions
- Ntp, Inc. v. Research in Motion, Ltd.Court of Appeals for the Federal Circuit · 2005
- Amgen Inc. v. F. Hoffmann-La Roche Ltd.Court of Appeals for the Federal Circuit · 2009
- Symbol Technologies, Inc. v. Opticon, Inc., and Opto ElectronicsCourt of Appeals for the Federal Circuit · 1991
- Nicholas v. Perricone, M.D. v. Medicis Pharmaceutical Corporation, Defendant-CrossCourt of Appeals for the Federal Circuit · 2005
- In Re Paolo LongiCourt of Appeals for the Federal Circuit · 1985
11 more not listed; retrieve them via the Exa API.
3Cited by29 opinions
- Eli Lilly and Company v. Teva Parenteral MedicinesCourt of Appeals for the Federal Circuit · 2017
- Genetics Institute, LLC v. Novartis Vaccines & Diagnostics, Inc.Court of Appeals for the Federal Circuit · 2011
- AbbVie Inc. v. Mathilda & Terrance Kennedy Institute of Rheumatology TrustCourt of Appeals for the Federal Circuit · 2014
- Gilead Sciences, Inc. v. Natco Pharma LimitedCourt of Appeals for the Federal Circuit · 2014
- Federal Trade Commission v. Boehringer Ingelheim Pharmaceuticals, Inc.District Court, District of Columbia · 2016
24 more not listed; retrieve them via the Exa API.